Knowles (KN) Q4 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2025 earnings summary
12 Apr, 2026Executive summary
Achieved a breakthrough year by completing the transformation into an industrial technology leader focused on MedTech, Defense, Industrial, and Energy markets, exceeding Investor Day expectations and leveraging a proven M&A strategy.
Revenue and EPS both surpassed guidance for Q4 and full year, driven by strong performance in MedTech, Specialty Audio, and Precision Devices.
Robust bookings, a strong backlog, and new design wins position the company for continued growth into 2026 and beyond.
Demonstrated strong historical financial performance, with robust margin expansion and a differentiated competitive advantage through customization at scale.
Financial highlights
Q4 2025 revenue was $162.2 million, up 13.8% year-over-year, exceeding the high end of guidance.
Full year 2025 revenue reached $593.2 million, up 7.2% year-over-year.
Q4 2025 non-GAAP diluted EPS was $0.36, up 33.3% year-over-year; full year non-GAAP diluted EPS was $1.11, up 20.7%.
Q4 2025 gross margin was 51.9%, up from 50% a year ago; Precision Devices segment Q4 gross margin was 40.1%.
Net cash provided by operating activities was $114 million for the full year, representing 19.2% of revenues.
Outlook and guidance
Q1 2026 revenue guidance is $143–$153 million, with non-GAAP diluted EPS expected between $0.22 and $0.26.
Q1 2026 adjusted EBIT margin projected at 18%-20%.
2026–2029 targets: 8–10% revenue CAGR, 10–14% adjusted EBITDA CAGR, and 16–20% cash from operations as a percentage of revenue.
Full year capital spending expected to support capacity expansion for large energy orders.
Anticipates strong organic revenue growth above historic levels for 2026, with margin expansion potential in the back half of the year.
Latest events from Knowles
- Q1 2026 saw 16% revenue growth and 50% higher non-GAAP EPS, with strong Q2 guidance.KN
Q1 202627 Apr 2026 - Annual meeting covers director elections, executive pay, and auditor ratification for 2026.KN
Proxy Filing11 Mar 2026 - 2026 proxy covers director elections, executive pay, auditor ratification, and robust governance.KN
Proxy Filing11 Mar 2026 - Portfolio shift to MedTech, defense, and industrial boosts margins and growth outlook.KN
2024 Southwest IDEAS Conference3 Feb 2026 - Targets 8–10% annual revenue growth and 10–14% EBITDA growth through organic and M&A strategies.KN
Investor Day 20253 Feb 2026 - Q2 revenue up 18.3% to $204.7M; $249.4M goodwill impairment drove $259M net loss.KN
Q2 20242 Feb 2026 - Q3 revenue up 32% year-over-year; strategic divestiture and margin gains position for growth.KN
Q3 202418 Jan 2026 - Q1 2025 revenue hit $132.2M, with strong cash flow and robust Precision Devices demand.KN
Q1 202526 Dec 2025 - 2024 revenue up 21% and non-GAAP EPS up 32%, with strong cash flow and major new orders.KN
Q4 202423 Dec 2025